Literature DB >> 7766607

Molecular dynamics of the anti-fluorescein 4-4-20 antigen-binding fragment. 2. Time-resolved fluorescence spectroscopy.

K Lim1, D M Jameson, C A Gentry, J N Herron.   

Abstract

Time-resolved fluorescence experiments were performed to investigate the dynamic aspects of the antigen-binding fragment (Fab) of a high-affinity monoclonal antibody (4-4-20) which binds the fluorescent hapten fluorescein. Both the unliganded Fab and a complex of the Fab with a nonfluorescent analog of fluorescein (fluoresceinamine, FLM) were examined. A fluorescence polarization probe [5-[[2-[(iodoacetyl)amino]ethyl]amino]naphthalene-1-sulfonic acid, AEDANS] was covalently attached to the C-terminus of the Fab. Experiments were performed at three different temperatures (10, 25, and 35 degrees C), and phase-modulation data sets were collected for five different molar ratios of FLM to Fab at each temperature. Global analyses were then used to extract values for fluorescence lifetime and rotational correlation time from these data. In the lifetime analysis the best fit was obtained when the emission of AEDANS was described by a Lorentzian distribution of lifetimes (tau = 15.6 ns, distribution width = 3.4 ns, both at 25 degrees C), which suggested that the probe experienced a heterogeneous environment. Anisotropy analyses suggested that two different rotational components were present. The first was attributed to the global motion of the Fab and exhibited a rotational correlation time (theta 1) of ca. 33 ns at 25 degrees C. This component was relatively unaffected by antigen binding. The second rotational component was attributed to the local or segmental motion within the Fab and exhibited a rotational correlation time (theta 2) of 1.1 ns at 25 degrees C. This value increased by more than 50% upon antigen binding, a result which was consistent with molecular dynamics simulations of the same Fab--fluorescein system [Lim & Herron (1995) Biochemistry 34, 6962-6974]. Furthermore, statistical analysis showed that this increase was significant at the 95% confidence level.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7766607     DOI: 10.1021/bi00021a009

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  Directed evolution of antibody fragments with monovalent femtomolar antigen-binding affinity.

Authors:  E T Boder; K S Midelfort; K D Wittrup
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

2.  Molecular description of flexibility in an antibody combining site.

Authors:  Jörg Zimmermann; Floyd E Romesberg; Charles L Brooks; Ian F Thorpe
Journal:  J Phys Chem B       Date:  2010-06-03       Impact factor: 2.991

3.  A mutation designed to alter crystal packing permits structural analysis of a tight-binding fluorescein-scFv complex.

Authors:  Annemarie Honegger; Silvia Spinelli; Christian Cambillau; Andreas Plückthun
Journal:  Protein Sci       Date:  2005-10       Impact factor: 6.725

4.  Context-dependent mutations predominate in an engineered high-affinity single chain antibody fragment.

Authors:  Katarina S Midelfort; K Dane Wittrup
Journal:  Protein Sci       Date:  2006-02       Impact factor: 6.725

5.  Molecular evolution of affinity and flexibility in the immune system.

Authors:  Ian F Thorpe; Charles L Brooks
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-08       Impact factor: 11.205

6.  Identification of Tyr residues that enhance folate substrate binding and constrain oscillation of the proton-coupled folate transporter (PCFT-SLC46A1).

Authors:  Michele Visentin; Ersin Selcuk Unal; Mitra Najmi; Andras Fiser; Rongbao Zhao; I David Goldman
Journal:  Am J Physiol Cell Physiol       Date:  2015-01-21       Impact factor: 4.249

Review 7.  Advances in the Understanding of Protein-Protein Interactions in Drug Metabolizing Enzymes through the Use of Biophysical Techniques.

Authors:  Jed N Lampe
Journal:  Front Pharmacol       Date:  2017-08-08       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.